Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illicit Use | Brian Hurley, MD, MBA, FAPA, DFASAM

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

Co-Occurring Disorder | Sokolski

Course outline

Course progress

Not started
2024 Board Exam Preparation: Pre-Assessment
Open/Close details
- Optional
Not started
Opioids and Pain
Open/Close details
- Optional
Not started
Nicotine and Nicotine Use Disorder
Open/Close details
- Optional
Not started
Basic Science and Addiction
Open/Close details
- Optional
Not started
Benzodiazepines
Open/Close details
- Required
Not started
Preventive Medicine and Epidemiology
Open/Close details
- Optional
Not started
Legal Aspects of Addiction Medicine
Open/Close details
- Optional
Not started
Hallucinogens and Psychedelics
Open/Close details
- Optional
Not started
Cannabis
Open/Close details
- Optional
Not started
Medical Complications
Open/Close details
- Optional
Not started
Maternal Fetal Complications
Open/Close details
- Optional
Not started
Adolescent Substance Abuse and Special Populations
Open/Close details
- Optional
Not started
Alcohol and Alcohol Use Disorders
Open/Close details
- Optional
Not started
Co-Occurring Disorders and Psychosocial Treatments
Open/Close details
- Optional
Not started
Psychosocial Screening Tools and Interventions
Open/Close details
- Optional
Not started
Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi
Open/Close details
- Optional
Not started
Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova
Open/Close details
- Optional
Not started
Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD
Open/Close details
- Required
Not started
Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD
Open/Close details
- Required
Not started
Knowledge Check: 2023 Board Exam Preparation Assessment
Open/Close details
- Required
Not started
Evaluations
Open/Close details
- Required
Not started
Credit
Open/Close details
- Optional
Not started
Certificate
Open/Close details
- Optional

Expand / Minimize

CSAM Education Center

2024 Addiction Medicine Board Exam Preparation Course

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

2024 Board Exam Preparation: Pre-Assessment

Opioids and Pain

Nicotine and Nicotine Use Disorder

Basic Science and Addiction

Benzodiazepines

Preventive Medicine and Epidemiology

Legal Aspects of Addiction Medicine

Hallucinogens and Psychedelics

Cannabis

Medical Complications

Maternal Fetal Complications

Adolescent Substance Abuse and Special Populations

Alcohol and Alcohol Use Disorders

Co-Occurring Disorders and Psychosocial Treatments

Psychosocial Screening Tools and Interventions

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova

Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD

Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD

Knowledge Check: 2023 Board Exam Preparation Assessment

Evaluations

Credit

Certificate

Course navigation

You are here

2024 Addiction Medicine Board Exam Preparation Course

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

2024 Board Exam Preparation: Pre-Assessment

Opioids and Pain

Nicotine and Nicotine Use Disorder

Basic Science and Addiction

Benzodiazepines

Preventive Medicine and Epidemiology

Legal Aspects of Addiction Medicine

Hallucinogens and Psychedelics

Cannabis

Medical Complications

Maternal Fetal Complications

Adolescent Substance Abuse and Special Populations

Alcohol and Alcohol Use Disorders

Co-Occurring Disorders and Psychosocial Treatments

Psychosocial Screening Tools and Interventions

Changing DEA Telehealth/Stimulant Access (ADHD) / Dark Web Element, Prescription Stimulants Shortage and Increased Risk for Illi

Psychedelics | Anna Lembke, MD | Brian Anderson, MD | Danielle Nova

Cannabis & Psychedelics: Policy Landscape and Public Health Impacts | Beau Kilmer, PhD

Broadening the Scope: Should Methadone Remain Siloed to OTPs? Scott Steiger, MD | Hillary Kunis, MD

Knowledge Check: 2023 Board Exam Preparation Assessment

Evaluations

Credit

Certificate

Course navigation